Technical Analysis for KROS - Keros Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 28.0 -1.48% -0.42
KROS closed down 1.48 percent on Thursday, May 28, 2020, on 57 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical KROS trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Inside Day Range Contraction 0.00%
Crossed Above 20 DMA Bullish -1.48%
Multiple of Ten Bearish Other -1.48%
Upper Bollinger Band Touch Strength -1.48%
Hot IPO Pullback Bullish Swing Setup 4.63%
Down 3 Days in a Row Weakness 4.63%
Lower Bollinger Band Touch Weakness 4.63%
Hot IPO Pullback Bullish Swing Setup 2.53%
NR7 Range Contraction 2.53%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis. It is also developing small molecule product candidate KER-047 that is being developed for the treatment of anemia, as well as for the treatment of fibrodysplasia ossificans progressiva, or FOP, and is currently in a Phase 1 clinical trial; and KER-012 being developed for the treatment of disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension, or PAH. The company was founded in 2015 and is headquartered in Lexington, Massachusetts.
Biopharmaceutical Medical Specialties Organ Systems Rare Diseases Disorders Pulmonary Arterial Hypertension Anemia Myelodysplastic Syndrome Hematology Osteoporosis Genodermatoses Myelodysplastic Syndromes Myelofibrosis Blood Disorders Hematopathology Thrombocytopenia

Is KROS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 32.75
52 Week Low 24.5
Average Volume 56,076
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 28.10
10-Day Moving Average 27.80
Average True Range 2.49
ADX 12.42
+DI 22.49
-DI 14.63
Chandelier Exit (Long, 3 ATRs ) 25.27
Chandelier Exit (Short, 3 ATRs ) 33.08
Upper Bollinger Band 29.75
Lower Bollinger Band 26.44
Percent B (%b) 0.47
BandWidth 11.78
MACD Line -0.30
MACD Signal Line -0.30
MACD Histogram -0.0049
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.57
Resistance 3 (R3) 30.52 29.63 30.14
Resistance 2 (R2) 29.63 28.97 29.65 29.99
Resistance 1 (R1) 28.81 28.57 28.37 28.86 29.85
Pivot Point 27.92 27.92 27.69 27.94 27.92
Support 1 (S1) 27.10 27.26 26.66 27.15 26.15
Support 2 (S2) 26.21 26.86 26.23 26.01
Support 3 (S3) 25.39 26.21 25.86
Support 4 (S4) 25.44